2485: hVIVO Interim Results: Mo Khan on Guidance, Growth and What Comes Next

hVIVO CEO Mo Khan discusses the company’s interim performance, FY26 guidance and the progress of its end-to-end clinical services strategy. He also addresses the CFO transition, the CRS Berlin acquisition and hVIVO’s longer-term growth outlook. #HVO #CRS